Kyle Malady - May 18, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Kyle Malady
Stock symbol
DXCM
Transactions as of
May 18, 2023
Transactions value $
$3
Form type
4
Date filed
5/22/2023, 03:47 PM
Previous filing
May 15, 2023
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $2.89 +2.89K +22.82% $0.00* 15.5K May 18, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Included in this number are 4,581 unvested restricted stock units, 2,885 of which were granted on May 18, 2023 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2024 Annual Meeting and 1,696 of which were granted on October 11, 2020 and shall vest through October 11, 2023.